MCMurilo Bicudo Cintra

Murilo Bicudo Cintra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Murilo Bicudo Cintra has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Radiologic Evaluation of the Nasopharynx: A Comprehensive Review

    by Carlos Alberto Ferreira Coelho Neto, Raphael Machado Reali, Soraia Ale Souza, Daniel Vaccaro Sumi, Murilo Bicudo Cintra, Regina Lúcia Elia Gomes, Carolina Ribeiro Soares, Eloisa Maria Santiago Gebrim, Tabassum A. Kennedy, Marcio Ricardo Taveira Garcia

    CT and MRI assist in evaluation of the anatomy and spectrum of nasopharyngeal disease such as eustachian tube dysfunction, Tornwaldt cysts, adenoid hypertrophy, and nasopharyngeal tumors, and identification of key imaging features supports accurate diagnosis, treatment planning, and posttherapy monitoring.

  • Open Access

    Benign and malignant lesions of the mandible and maxilla: imaging findings and systematic approach

    by Leonor Garbin Savarese, Murilo Bicudo Cintra, Marcello Henrique Nogueira-Barbosa, Gustavo Santos Boasquevisque

    Although lesions of the mandible and maxilla are relatively common findings on imaging examinations, they still pose a diagnostic challenge for radiologists in clinical practice. Many of these lesions share similar radiographic characteristics, making it difficult to differentiate between benign, infectious, and malignant entities, which can delay appropriate management. This article aims to illustrate the main imaging findings and present a systematic approach based on radiological patterns, such as attenuation type, margins, relationship with dental structures, and anatomical distribution, in order to facilitate the differential diagnosis, as well as to guide clinical and therapeutic management.

    • 27 December 2024
      • Vol. 57, e13en
    Open Access

    Thyroid orbitopathy

    by Murilo Bicudo Cintra

  • Open Access

    Thyroid orbitopathy

    by Murilo Bicudo Cintra

    Graves’ disease is an autoimmune condition and the most common cause of hyperthyroidism in countries with iodine sources. In this disease, B lymphocytes produce high levels of thyroid-stimulating hormone receptor antibodies, which bind to those receptors in the thyroid gland, promoting glandular enlargement and hypersecretion of thyroid hormones. In the general population, Graves’ disease has a prevalence of 1.0-1.5%, with an annual incidence of approximately 20-30 new cases per 100,000 population. Graves’ disease mainly affects individuals between 30 and 60 years of age, is 5-10 times more common in women, and has a higher incidence among individuals of African descent. Genetic predisposition carries a risk of up to 79% of developing the disease, whereas environmental factors account for a risk of approximately 21%(1,2).

  • Open Access

    Orbitopatia tireoidiana

    by Murilo Bicudo Cintra

    A doença de Graves é uma afecção autoimune e a causa mais comum de hipertireoidismo em países com fontes de iodo. Nesta doença, os linfócitos B produzem altos níveis de TRAb - anticorpos antirreceptores de TSH -, que se ligam aos receptores de TSH na glândula tireoide, promovendo aumento glandular e hipersecreção dos hormônios tireoidianos. A prevalência da doença de Graves na população em geral é de 1,0% a 1,5% e cerca de 20 a 30 novos casos se manifestam a cada 100.000 habitantes por ano. A doença de Graves atinge principalmente indivíduos com idade entre 30 e 60 anos, é 5 a 10 vezes mais frequente nas mulheres e a incidência é maior nos descendentes afro-americanos. Há uma predisposição genética com o risco de até 79% de desenvolver a doença, enquanto fatores ambientais contribuem com aproximadamente 21%(1,2).

  • Adverse Radiation Therapy Effects in the Treatment of Head and Neck Tumors

    by Pedro H. P. Rocha, Raphael M. Reali, Marcos Decnop, Soraia A. Souza, Lorine A. B. Teixeira, Ademar Lucas Júnior, Maíra O. Sarpi, Murilo B. Cintra, Marco C. Pinho, Marcio R. T. Garcia

    Radiation therapy has an essential role in the treatment of head and neck malignancies, but radiation-induced adverse effects remain a clinical issue and are recognizable at CT and MRI. Whether used as a single modality or as part of a combined approach, radiation therapy (RT) plays an essential role in the treatment of several head and neck malignancies. Despite the improvement i...


  • CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma

    by Pritam Mukherjee, Murilo Cintra, Chao Huang, Mu Zhou, Shankuan Zhu, A. Dimitrios Colevas, Nancy Fischbein, Olivier Gevaert

    Radiomics features extracted from CT images showed significant performance for predicting histopathologic features such as tumor grade, extracapsular spread, lymphovascular invasion, perineural inv... Purpose To determine the performance of CT-based radiomic features for noninvasive prediction of histopathologic features of tumor grade, extracapsular spread, perineural invasion, lymphovascular i...


  • Open Access

    Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes

    by Chao Huang, Murilo Cintra, Kevin Brennan, Mu Zhou, A. Dimitrios Colevas, Nancy Fischbein, Shankuan Zhu, Olivier Gevaert


  • Monitoring optic chiasmatic-hypothalamic glioma volumetric changes by MRI in children under clinical surveillance or chemotherapy

    by Nathalia Cunha Calixto, Gustavo Novelino Simão, Antonio Carlos dos Santos, Ricardo Santos de Oliveira, Luiz Guilherme Darrigo Junior, Elvis Terci Valera, Murilo Bicudo Cintra, Alessandro Spano Mello

    Optic pathway gliomas represent 5% of pediatric brain tumors and are typically low-grade lesions. Because of their unpredictable clinical course, adequate treatment approaches have been controversial, involving surveillance, surgery, chemotherapy, and radiotherapy. In this study, we use volumetric imaging to compare evolution of optic chiasmatic-hypothalamic gliomas (OCHG) treated with and without chemotherapy, analyzing tumor volume variation during the overall period.


  • Open Access

    Magnetic resonance imaging: dynamic contrast enhancement and diffusion-weighted imaging to identify malignant cervical lymph nodes

    by Murilo Bicudo Cintra, Hilton Ricz, Mahmood F. Mafee, Antonio Carlos dos Santos

    Objective: To examine the potential of two magnetic resonance imaging (MRI) techniques-dynamic contrast enhancement (DCE) and diffusion-weighted imaging (DWI)-for the detection of malignant cervical lymph nodes. Materials and Methods: Using DCE and DWI, we evaluated 33 cervical lymph nodes. For the DCE technique, the maximum relative enhancement, relative enhancement, time to peak enhancement, wash-in rate, wash-out rate, brevity of enhancement, and area under the curve were calculated from a semi-quantitative analysis. For the DWI technique, apparent diffusion coefficients (ADCs) were acquired in the region of interest of each lymph node. Cystic or necrotic parts were excluded. All patients underwent neck dissection or node biopsy. Imaging results were correlated with the histopathological findings. None of the patients underwent neoadjuvant treatment before neck dissection. Results: Relative enhancement, maximum relative enhancement, and the wash-in rate were significantly higher in malignant lymph nodes than in benign lymph nodes (p < 0.009; p < 0.05; and p < 0.03, respectively). The time to peak enhancement was significantly shorter in the malignant lymph nodes (p < 0.02). In the multivariate analysis, the variables identified as being the most capable of distinguishing between benign and malignant lymph nodes were time to peak enhancement (sensitivity, 73.7%; specificity, 69.2%) and relative enhancement (sensitivity, 89.2%; specificity, 69.2%). Conclusion: Although DCE was able to differentiate between benign and malignant lymph nodes, there is still no consensus regarding the use of a semi-quantitative analysis, which is difficult to apply in a clinical setting. Low ADCs can predict metastatic disease, although inflammatory processes might lead to false-positive results.